Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
729.8 EUR | +0.40% | +4.47% | +37.57% |
02:24pm | Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1 | RE |
07:42am | Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast | RE |
Sales 2024 * | 43.03B 40.19B | Sales 2025 * | 51.95B 48.51B | Capitalization | 699B 653B |
---|---|---|---|---|---|
Net income 2024 * | 12.03B 11.23B | Net income 2025 * | 16.09B 15.03B | EV / Sales 2024 * | 16.7 x |
Net Debt 2024 * | 20.93B 19.54B | Net Debt 2025 * | 13.85B 12.93B | EV / Sales 2025 * | 13.7 x |
P/E ratio 2024 * |
57.4
x | P/E ratio 2025 * |
42.8
x | Employees | 43,000 |
Yield 2024 * |
0.67% | Yield 2025 * |
0.77% | Free-Float | 99.83% |
Latest transcript on Eli Lilly and Company
1 day | +0.39% | ||
1 week | +4.47% | ||
Current month | -0.03% | ||
1 month | +1.86% | ||
3 months | +21.73% | ||
6 months | +36.40% | ||
Current year | +37.57% |
Managers | Title | Age | Since |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 95-12-31 |
Anat Ashkenazi
DFI | Director of Finance/CFO | 51 | 00-12-31 |
Ruth Gimeno
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 21-01-24 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 09-03-31 |
Jon Fyrwald
BRD | Director/Board Member | 63 | 04-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 724.3 | -0.36% | 242 |
24-04-30 | 726.9 | +5.78% | 717 |
24-04-29 | 687.2 | +0.12% | 780 |
24-04-26 | 686.4 | +1.39% | 542 |
24-04-25 | 677 | -1.02% | 556 |
Delayed Quote Deutsche Boerse AG, May 02, 2024 at 08:48 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.43% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.68% | 236B | |
+4.50% | 198B | |
-11.04% | 194B | |
-5.59% | 154B | |
-3.69% | 149B |
- Stock Market
- Equities
- LLY Stock
- LLY Stock